Filing shows Salesforce paid $419M to buy Spiff in February

The Salesforce building near Bryant Park in New York City

Image Credits: Alexi Rosenfeld / Getty Images

Salespeople live and die by commissions, which typically form a big chunk of how they are paid. It’s no surprise, then, that Salesforce paid a premium to buy a platform that helps its customers manage commissions more easily.

Several months ago, Salesforce bought Spiff to help companies build out and manage incentive-based compensation schemes. Salesforce’s 10-Q filing with the SEC early on Thursday finally revealed the price it paid: $419 million all-in.

That price, described as “acquisition date fair value,” includes $374 million in cash, the filing said.

The 10-Q followed Salesforce’s quarterly results, which it reported on Wednesday. The company’s stock dropped by some 16% on Wednesday after its quarterly revenue came in below analysts’ expectations for the first time in about 18 years (it last reported a revenue miss in 2006). The company recorded quarterly revenues of $9.13 billion, below analysts average estimates of $9.15 billion, per Yahoo Finance.

Given that context, an acquisition to drive more revenues down the line is not a surprise.

The $419 million price tag is a notable hike for Spiff. The startup was last valued, according to PitchBook, at $260 million as recently as May 2023 when it raised $50 million.

That was just seven months before Salesforce and Spiff announced their deal in December 2023. The deal closed in February 2024, according to the 10-Q.

Based out of Salt Lake City, Utah, Spiff had raised around $110 million in total from investors including Salesforce, Lightspeed Venture Partners, Norwest Ventures, and a number of notable backers such as UiPath’s founder Daniel Dines, and Hanno Renner, the head and founder of HR startup Personio.

Spiff’s acquisition and the deal’s value are notable because they are very much a sign of the times.

Such a strong uptick in value close on the heels of a fundraise can be seen as a signal of how stronger companies are still commanding good prices despite wider pressure on startups.

The IPO window is still mostly closed for many mature startups, leading to a tougher funding market overall. And when we combine that with tough economic conditions that have seen companies fail to meet growth targets, we’re seeing struggling startups having to settle for down-rounds, conducting fire sales, and in the worst-case scenarios, sinking in the deadpool.

That’s not the case with Spiff. At the time of its last funding round a year ago, the company said its customer base had doubled to 1,000, and its revenue had risen 100% in the last year. The company was founded during the pandemic, and it says its revenue has increased 800% since then.

More recently, Spiff has been leaning into buzzy areas that Salesforce likely wants to capture: AI, and no-code, self-service solutions.

Specifically, Spiff last year launched an AI-based, no-code, self-service toolset that its customers could use to build sales commission schemes without needing developers. Extra flexibility becomes a priority when the economy is not at its strongest, and that’s where Spiff was aiming its new technology.

“We’ve seen a lot of commission plans change,” Jeron Paul, Spiff’s founder and CEO, told TechCrunch in an interview last year. “Incentives end up driving a lot of the behavior of your go-to-market motion, so when you hit recessions, and whatever we’re in right now, that go-to-market motion changes a lot, which means your commission plans change a lot.”

To that end, Salesforce said it is recording $323 million of goodwill covering “assembled workforce and expanded market opportunities.”

Salesforce also noted in the 10-Q that it is ascribing $52 million in “intangible assets” in the value of the Spiff deal, which includes nine years of life for the startup’s existing technology, and a further five years for its existing customer book.

Shot of a medical practitioner using a digital tablet in a hospital ward

Healthcare platform Anima brings Salesforce-like capabilities to clinics, raises $12M

Shot of a medical practitioner using a digital tablet in a hospital ward

Image Credits: Getty Images

Globally, healthcare IT systems are groaning under the weight of legacy platforms. Thankfully, there’s a new wave of startups entering the arena: U.K. startup Anima is a “care enablement” platform that operates almost like a combination of Slack, Salesforce and Figma, but for healthcare clinics and hospitals.

The company recently raised a $12 million Series A funding round led by Molten Ventures, with participation from existing investors Hummingbird Ventures, Amino Collective and Y Combinator, as well as new angel investors including Sidar Sahin, founder of Peak Games.

Anima, a graduate of Y Combinator’s Winter 2021 batch, launched in September 2022 and is now used in 150 NHS clinics in England. The startup’s software lets clinic staff process and file healthcare documents, but adds in a higher degree of automation compared to legacy systems.

“Anima can take a specific medical history, autonomously, for any presenting complaint, and present this to the clinic with potential differential diagnoses and suggested next steps, ensuring red flags are not missed,” Shun Pang, co-founder and CEO of Anima, told TechCrunch. “The entire clinic collaborates in a real-time multiplayer dashboard, like Figma, and can ping cases to each other, and chat with a Slack-like UX.” he said.

He also added that Anima’s processing system can “autonomously ingest any document, like handwritten, diagrams, imaging, and output a summary, with structured fields.”

Competitors in this space include U.K.-based accuRx, which is post-Series B and has raised £36.6 million to date. In the U.S., Memora Health has raised $80.5 million, and NexHealth, which is post-Series C, has raised $177.2 million to date.

Pang told me, “We see our real competitors as any company with a credible path to a ‘care enablement’ platform, which captures the clinical workflow from ingestion to resolution, akin to what Rippling did for HR, or Salesforce for distribution.”

He is also somewhat of an unusual founder in this space, as he was a practicing doctor prior to this startup: “I’m doubly technical. I trained as a doctor at Cambridge, and I’m a self-taught software engineer who wrote a lot of the code for Anima. I was essentially building what I myself had wanted, and knew would save lives.”

Given its traction and founder hinterland, Anima has managed to make encouraging inroads into the NHS, which is said to be notoriously tricky to deal with.

Inga Deakin, a principal at Molten Ventures, said in a statement: “Software and artificial intelligence (AI) in healthcare is a rapidly growing multi-$bn sector, but many solutions take time to integrate and realise their potential… Anima is growing rapidly, because they can directly and immediately have an impact.”